Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M328Revenue $M86.9Net Margin (%)-77.3Altman Z-Score0.4
Enterprise Value $M234EPS $-0.9Operating Margin %-58.4Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)-77.1Higher ROA y-yN
Price/Book2.910-y EBITDA Growth Rate %-51.5Quick Ratio5.8Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %3.4Current Ratio6.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-32.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-101.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M85.1ROIC % (ttm)-264.3Gross Margin Increase y-yN

Gurus Latest Trades with RPTP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RPTPJoel Greenblatt 2015-09-30 Sold Out $5.69 - $15.79
($12.35)
$ 3.85-69%Sold Out0
RPTPJoel Greenblatt 2015-06-30 Buy $9.64 - $16.13
($12.13)
$ 3.85-68%New holding18,396
RPTPJoel Greenblatt 2014-12-31 Sold Out $8.04 - $11.01
($9.75)
$ 3.85-61%Sold Out0
RPTPJoel Greenblatt 2014-09-30 Buy $8.09 - $11.54
($10.22)
$ 3.85-62%New holding22,595
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RPTP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RPTP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bruhn Suzanne LouiseDirector 2015-09-09Sell18,258$12.47-69.29view
Anderson RaymondDirector 2015-09-02Sell4,916$12.51-69.38view
Anderson RaymondDirector 2015-08-31Sell8,084$12.52-69.41view
Keltner LlewDirector 2015-07-01Sell50,000$16.05-76.14view
Daley Thomas EChief Business Officer 2015-06-18Sell35,000$15-74.47view
Bruhn Suzanne LouiseDirector 2015-06-10Sell30,000$13.45-71.52view
Daley Thomas EChief Business Officer 2015-05-20Sell10,000$12-68.08view
FRANKLIN RICHARD LDirector 2015-05-04Sell10,000$9.61-60.15view
FRANKLIN RICHARD LDirector 2015-04-02Sell10,000$10.37-63.07view
Anderson RaymondDirector 2015-03-24Sell21,619$12-68.08view

Quarterly/Annual Reports about RPTP:

    News about RPTP:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Feb 09 2016
    Raptor Pharmaceutical to Participate in the Leerink Partners 5th Global Healthcare Conference Feb 08 2016
    These Biotech Companies are Helping Turn Around the Sector for Major Gains in 2016 Feb 03 2016
    Biotech Sector Report; Potential Rebound for These Four Biotech Securities Feb 01 2016
    Raptor Pharma upgraded by Citigroup Jan 27 2016
    Four New Patents Issued, PROCYSBI® Granted Additional U.S. Orphan Exclusivity Jan 25 2016
    Four New Patents Issued, PROCYSBI® Granted Additional U.S. Orphan Exclusivity Jan 25 2016
    8 Stocks Moving In Wednesday's After-Hours Session Jan 20 2016
    Technical Report on Biotechnology Stocks -- Raptor Pharma, Advaxis, Lion Biotechnologies, and Akebia... Dec 22 2015
    Raptor Pharmaceutical Corp. Earnings Analysis: Q3, 2015 By the Numbers Dec 21 2015
    Raptor Reports Efficacy Data from CYST-HD Study on RP103 Dec 11 2015
    REUTERS AMERICA NEWS PLAN FOR THURSDAY DEC 10 Dec 10 2015
    Raptor to advance neurodegenerative disorder drug in registration study Dec 10 2015
    Raptor Plans to Advance RP103 in a Registration Study in Huntington's Disease Based on Favorable... Dec 10 2015
    RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 10 2015
    Raptor Plans to Advance RP103 in a Registration Study in Huntington's Disease Based on Favorable... Dec 10 2015
    RAPTOR PHARMACEUTICAL CORP Financials Dec 08 2015
    Raptor Pharmaceutical Corp. breached its 50 day moving average in a Bearish Manner : December 4,... Dec 04 2015
    Hedge Funds Are Crazy About Carmike Cinemas, Inc. (CKEC) Nov 27 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK